ERBB2 and breast cancer: In our study, we report growth inhibition, targeted suppression of putative MaSC/CSC-enriched populations, and modulation of cell stemness, as measured by various analyses, in cellular, syngeneic, and transgenic models of erbB-2-overexpressing breast cancer.